Radiopharmaceutical biotech and contract development and organization firm Duchembio Co. Ltd. filed a securities report to South Korea’s Financial Services Commission Nov. 11, kickstarting the IPO ...

they are going to be a little bit tough because the scrap spreads are tightened. So I think that for the IPO, we will wait till we are happy with the market conditions," Pai said. He flagged that ...

“Through the scoping phase, we have assessed both a trade sale and an IPO as attractive divestment options and will now prepare for a sale process which will pursue both options,” said Hurrell.

Retailer Groupe Dynamite Inc. says shares up for grabs in an initial public offering it launched will be priced between $19 ...